(Q35582306)

9 August 2017

1 reference

title

Opioid therapy for chronic pain (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMRA025411

9 August 2017

Opioid Therapy for Chronic Pain (English)

1 reference

1 April 2024

0 references

0 references

1

Jane C Ballantyne

1 reference

9 August 2017

Jianren Mao

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

13 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14614170

reference URL

full work available at URL

1 April 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMra025411

1 reference

https://api.crossref.org/works/10.1056/NEJMRA025411

The New England Journal of Medicine

1 April 2024

published in

1 reference

9 August 2017

volume

349

1 reference

9 August 2017

issue

20

1 reference

9 August 2017

page(s)

1943-1953

1 reference

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

9 August 2017

cites work

https://api.crossref.org/works/10.1056/NEJMRA025411

2

1 reference

Opioids in pain management

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

3

1 reference

Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

4

1 reference

Self-reported vs. actual use of medications in chronic pain patients

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

5

1 reference

Drug utilization patterns in chronic pain patients

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

6

1 reference

Prescription medication dependence and neuropsychologic function.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

7

1 reference

Medication management in patients with chronic non-malignant pain. A review of the use of a drug withdrawal protocol

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

8

1 reference

Substance dependence and chronic pain: experience with treatment and follow-up results

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

9

1 reference

Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

10

1 reference

Opioid therapy for chronic nonmalignant pain: a review of the critical issues

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

12

1 reference

Long-term use of narcotic/antidepressant medication in the management of phantom limb pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

14

1 reference

Myofascial origins of low back pain. 2. Torso muscles

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

15

1 reference

Chronic Nonmalignant Pain Treated with Long-Term Oral Narcotic Analgesics

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

16

1 reference

Long-term oral opioid therapy in patients with chronic nonmalignant pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

17

1 reference

Oral methadone for managing chronic nonmalignant pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

19

1 reference

Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

20

1 reference

Transdermal fentanyl as treatment for chronic low back pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

21

1 reference

Codeine and oxycodone use in patients with chronic rheumatic disease pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

22

1 reference

Successful use of methadone in the treatment of chronic neuropathic pain arising from burn injuries: a case-study

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

23

1 reference

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

24

1 reference

Driving ability in cancer patients receiving long-term morphine analgesia

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

25

1 reference

Effects of opioids on driving ability

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

26

1 reference

Outcome of chronic opioid therapy for non-cancer pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

27

1 reference

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

28

1 reference

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

29

1 reference

Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

30

1 reference

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

31

1 reference

Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

32

1 reference

Oral opioid therapy for chronic peripheral and central neuropathic pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

33

1 reference

Opioids and chronic neuropathic pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

34

1 reference

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

35

1 reference

Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

36

1 reference

Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

37

1 reference

Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

39

1 reference

Opioid therapy for chronic noncancer back pain. A randomized prospective study.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

40

1 reference

Efficacy of analgesics in chronic pain: a series of N-of-1 studies

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

41

1 reference

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

42

1 reference

The Journal of Rheumatology

1 April 2024

43

26

862

Caldwell JR

1999

1 reference

https://api.crossref.org/works/10.1056/NEJMRA025411

Long-term opioid analgesic therapy for severe refractory lumbar spine pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

44

1 reference

Randomised trial of oral morphine for chronic non-cancer pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

45

1 reference

The Journal of Rheumatology

1 April 2024

46

19

764

Peloso PM

2000

1 reference

https://api.crossref.org/works/10.1056/NEJMRA025411

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

47

1 reference

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

48

1 reference

Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

49

1 reference

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

50

1 reference

Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

51

1 reference

A locus and mechanism of action for associative morphine tolerance

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

52

1 reference

A RAVE about opioid withdrawal

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

53

1 reference

Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

54

1 reference

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

55

1 reference

Delayed application of MK-801 attenuates development of morphine tolerance in rats

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

56

1 reference

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

58

1 reference

Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

59

1 reference

Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

60

1 reference

The effects of detoxification, relaxation, and brief supportive therapy on chronic pain

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

62

1 reference

Long-term opioid therapy: assessment of consequences and risks

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

63

1 reference

Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

64

1 reference

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

65

1 reference

Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

66

1 reference

Side effects of intrathecal and epidural opioids

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

67

1 reference

Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

69

1 reference

Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

70

1 reference

Multiple hormonal responses to morphine: relationship to diagnosis and dexamethasone suppression

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

71

1 reference

Effects of thyrotropin-releasing hormone on prolactin, growth hormone and corticosterone secretions in adult male rats treated with pentobarbital or morphine

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

72

1 reference

Endocrine effects of methadone in rats; acute effects in adults

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

73

1 reference

Evidence for morphine-induced galactorrhea in male cynomolgus monkeys

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

75

1 reference

Journal of the Pakistan Medical Association

1 April 2024

79

42

210

Malik SA

1992

1 reference

https://api.crossref.org/works/10.1056/NEJMRA025411

Hypogonadism in patients treated with intrathecal morphine

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

81

1 reference

Effects of opioids on the immune system

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

82

1 reference

1 April 2024

Opiates and infection

https://api.crossref.org/works/10.1056/NEJMRA025411

83

1 reference

Morphine receptors in immunocytes and neurons

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

84

1 reference

Abrupt or precipitated withdrawal from morphine induces immunosuppression

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

85

1 reference

Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

86

1 reference

Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats.

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

87

1 reference

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

88

1 reference

Stressor-induced alterations of immune function: mechanisms and issues

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

89

1 reference

Individual variability in the response to different opioids: report of five cases

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

90

1 reference

Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

93

1 reference

Methadone reincarnated: novel clinical applications with related concerns

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

95

1 reference

The pharmacology of mu analgesics: from patients to genes

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

97

1 reference

Opioid rotation for cancer pain: rationale and clinical aspects

1 April 2024

https://api.crossref.org/works/10.1056/NEJMRA025411

98

1 reference

1 April 2024

Identifiers

DOI

10.1056/NEJMRA025411

1 reference

9 August 2017

1 reference